Medical Marijuana, Inc. Subsidiary Dixie Botanicals™ Appoints New Director of Sales and Marketing Brent Albin

SAN DIEGO, July 3, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary Dixie Botanicals™, one of the most recognizable cannabis brands in the world, has appointed Brent Albin as Director of Sales and Marketing.

Albin brings to Dixie Botanicals® more than 10 years of experience in online advertising and social media promotion, capable of creating mass followings on social networks for organizations. He also served as Director of Business Development for General Hemp™, the world’s leading investment group supporting growth in the industrial hemp industry, where he was responsible for helping create Medical Marijuana, Inc.’s subsidiary Kannaway™, LLC. In addition, Albin served as Vice President of the Online Launch Agency, a Company focusing on social media advertising across several platforms.

“We are excited to bring Brent on board to the Dixie Botanicals team, as we believe his vast experience in creating strategic partnerships, building new brands and delivering new products to the world, will help make Dixie Botanical’s innovative CBD products the supplement of choice for even more customers across the globe,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus.

“I’m looking forward to helping Dixie Botanicals continue to ignite the hemp world, while bringing Medical Marijuana, Inc. a new bold style into the community,” said Albin. “My passion is bringing new concepts and products to light. We have both of those ingredients at Dixie Botanicals, which will lead to exciting times and new markets.”

Dixie Botanicals offers innovative cannabidiol (CBD) Hemp Oil products for health conscious consumers. The Company’s formulation experts include scientists, clinical herbalists and nutritionists who work to integrate CBD Hemp Oil into a variety of generally accepted beneficial and uniquely effective products.

About Dixie Botanicals
Regarded as one of the most well recognized brands in the industry, Dixie Botanicals™ offers innovative hemp oil products for health conscious consumers. Our formulation experts include scientists, clinical herbalists and nutritionists who work to integrate our hemp oil into a variety of unique products. Dixie Botanicals™ products contain naturally occurring cannabidiol (CBD) hemp oil from the mature stalk of the industrial hemp plant. We test and analyze our products from seed to shelf, ensuring that every natural product we offer is free from contaminants and of the highest quality possible. (Click to view test results.) For more information, visit: www.DixieBotanicals.com.

About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.

To see Medical Marijuana, Inc.’s video statement, click here.

Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.

FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Axim Biotechnologies, Inc. to be materially different from the statements made herein.